Ginkgo Bioworks Holdings (DNA) Other Working Capital Changes (2020 - 2026)

Ginkgo Bioworks Holdings (DNA) has reported Other Working Capital Changes for 7 consecutive years, with -$4.8 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Other Working Capital Changes rose 29.72% year-over-year to -$4.8 million; the trailing twelve-month figure through Jun 2026 stood at -$27.0 million (down 19.35% YoY), and the FY2025 full-year result was -$27.9 million, down 87.7% from the prior year.
• Other Working Capital Changes grew to -$4.8 million in Q2 2026 per DNA's latest filing, from -$5.9 million in the prior quarter.
• Across five years, Other Working Capital Changes topped out at $11.4 million in Q1 2022 and bottomed at -$50.8 million in Q3 2024.
• Historically, Other Working Capital Changes has averaged -$9.9 million across 5 years, with a median of -$5.9 million in 2023.
• The sharpest annual moves came in 2022 and 2025: Other Working Capital Changes surged 615.62% in 2022, then slumped 3064.5% in 2025.
• Over 5 years, Other Working Capital Changes stood at -$3.0 million in 2022, then plunged by 50.42% to -$4.5 million in 2023, then increased by 22.09% to -$3.5 million in 2024, then plunged by 161.26% to -$9.1 million in 2025, then jumped by 47.34% to -$4.8 million in 2026.
• According to Business Quant data, Other Working Capital Changes over the past three periods registered -$4.8 million, -$5.9 million, and -$9.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.